Binding and competitive inhibition of amine uptake at postsynaptic neurones (transport-P) by tricyclic antidepressants

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 811-816

  Al Damluji, S ^a,b   Kopin, I J ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Biological transport; Noradrenaline; Prazosin; Tricyclic antidepressants; Uptake

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMITRIPTYLINE; DESIPRAMINE; GONADORELIN; IMIPRAMINE; NORTRIPTYLINE; PRAZOSIN; RESERPINE; TERTIARY AMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AMINE TRANSPORT; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HYPOTHALAMUS; NERVE ENDING; NONHUMAN; NORADRENERGIC NERVE; PEPTIDERGIC NERVOUS SYSTEM; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL;

EID: 0029965503     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15265.x     Document Type: Article

References (44)

1. AL-DAMLUJI, S. (1993). Adrenergic control of the secretion of anterior pituitary hormones. Bailliere's Clinical Endocrinology and Metabolism, vol. 7, part 2, pp. 355-392.
2. AL-DAMLUJI, S. & KOPIN, I.J. (1996). Functional properties of the uptake of amines in immortalised peptidergic neurones (Transport-P). Br. J. Pharmacol., 117, 111-118.
3. AL-DAMLUJI, S. & KRSMANOVIC, L. (1992). High-affinity uptake of noradrenaline by GnRH cells. Abst. Endocr. Soc., 74, 197.
4. AL-DAMLUJI, S., KRSMANOVIC, L. & CATT, K.J. (1993). High-affinity uptake of noradrenaline in post-synaptic neurones. Br. J. Pharmacol., 109, 299-307.
5. ANONYMOUS (1982). Alpha-2 adrenergic receptors in depression. Lancet, i, 781.
6. ARONSTAM, R.S. (1981). Interactions of tricyclic antidepressants with a synaptic ion channel. Life Sci., 28, 59-64.
7. AXELROD, J. (1971). Noradrenaline: fate and control of its biosynthesis. Science, 173, 598-606.
8. BALDESSARINI, R.J. (1990). Drugs and the treatment of psychiatric disorders. In Pharmacological Basis of Therapeutics, ed. Gilman, A.G., Rail, T.W., Nies, A.S. & Taylor, P. pp. 405-435. New York: Pergamon Press, Eighth edition.
9. BARKER, E.L., KIMMEL, H.L. & BLAKELY, R.D. (1994). Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands. Mol, Pharmacol., 46, 799-807.
10. BOUVIER, M., SZATKOWSKI, M., AMATO, A. & ATTWELL, D. (1992). The glial cell glutamate uptake carrier countertransports pH-changing anions. Nature, 360, 471-474.
11. 1 in noradrenergic neurones. Naunyn-Schmied. Arch. Pharmacol., 345, 319-326.
12. CARLSSON, A. (1984). Current theories on the mode of action of antidepressant drugs. Adv. Biochem. Psychopharmacol., 39, 213-211.
13. DE LEAN, A., MUNSON, P.J. & RODBARD, D. (1978). Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am. J. Physiol., 235, E97-E102.
14. DEVANE, C.L. & JARECKE, C.R. (1992). Cyclic antidepressants. In Applied Pharmacokinetics. ed. Evans, E.E., Schentag, J.J., Jusko, W.J. & Relling, M.V. pp. 33-1 to 33-47. Vancouver: Applied Therapeutics, Inc. Third edition.
15. 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue. Biochem. Pharmacol., 38, 473-480.
16. FRISK-HOLMBERG, M. & KLEIJN, E.V.D. (1972). The relationship between the lipophilic nature of tricyclic neuroleptics and antidepressants, and histamine release. Eur. J. Pharmacol., 18, 139-147.
17. GIROS, B., WANG, Y.M., SUTER, S., MCLESKEY, S.B., PIFL, C. & CARON, M.G. (1994). Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J. Biol. Chem., 269, 15985-15988.
18. GRAEFE, K.H. & BONISCH, H. (1989). The transport of amines across axonal membranes of noradrenergic and dopaminergic neurones. In Handbook Exp. Pharmacol., ed. Trendelenburg, U. & Weiner, N. 90 (Part 1), pp. 193-245. Berlin: Springer-Verlag.
19. GRAM, L.F., KRAGH-SORENSEN, P., KRISTENSEN, C.B., MOLLER, M., PEDERSEN, O.L. & THAYSSEN, P. (1984). Plasma level monitoring of antidepressants: theoretical basis and clinical application. Adv. Biochem. Psychopharmacol., 39, 399-411.
20. HENN, F.A. & HAMBERGER, A. (1971). Glial cell function: uptake of transmitter substances. Proc. Natl. Acad. Sci. U.S.A., 68, 2686-2690.
21. HOSLI, L. & HOSLI, E. (1978). Action and uptake of neurotransmitters in CNS tissue culture. Rev. Physiol. Biochem. Pharmacol., 81, 135-188.
22. IVERSEN, L.L. (1965). The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catecholamine uptake process. Br. J. Pharmacol., 25, 18-33.
23. IVERSEN, L.L. (1967). The Uptake and Storage of noradrenaline in sympathetic nerves. Cambridge: University Press.
24. KANOF, P.D. & GREENGARD, P. (1978). Brain histamine receptors as targets for antidepressant drugs. Nature, 272, 329-333.
25. 3H]norepinephrine by primary astrocyte cultures and its inhibition by tricyclic antidepressants. J. Neurochem., 40, 1265-1270.
26. KOE, B.K. (1976). Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther., 199, 649-661.
27. LEONARD, B.E. (1993). The comparative pharmacology of new antidepressants. J. Clin. Psychiatry, 54, (suppl.), 315.
28. LESTER, H.A. MAGER, S., QUICK, M.W. & COREY, J.L. (1994). Permeation properties of neurotransmitter transporters. Annu. Rev. Pharmacol. Toxicol., 34, 219-249.
29. MAXWELL, R.A., FERRIS, R.M., BURCSU, J., WOODWARD, E.C., TANG, D. & WILLIARD, K. (1974). The phenyl rings of tricyclic antidepressants and related compounds as determinants of the potency of inhibition of the amine pumps in adrenergic neurons of the rabbit aorta and in rat cortical synaptosomes. J. Pharmacol. Exp. Ther., 191, 418-430.
30. MAXWELL, R.A., KEENAN, P.D., CHAPLIN, E., ROTH, B & ECKHARDT, S.B. (1969). Molecular features affecting the potency of tricyclic antidepressants and structurally related compounds as inhibitors of the uptake of tritiated norepinephrine by rabbit aortic strips. J Pharmacol. Exp. Ther., 166, 320-329.
31. MAXWELL, R.A. & WHITE, H.L. (1978). Tricyclic and monoamine oxidase inhibitor antidepressants: structure-activity relationships. In Handbook of Psychopharmacology. ed. Iversen, L.L., Iversen, S.D. & Snyder, S.H. London: Plenum Press. Volume 14, pp. 83-155.
32. MOFFAT, A.C. (1986). Clarke's isolation and identification of drugs. London: The Pharmaceutical Press.
33. MONTGOMERY, S.A. (1994). Antidepressants in long-term treatment. Annu. Rev. Med., 45, 447-457.
34. MORRIS, J.B. & BECK, A.T. (1974). The efficacy of antidepressant drugs. Arch. Gen. Psychiatry, 30, 667-674.
35. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem., 107, 220-239.
36. PACHOLCZYK, T., BLAKELY, R.D. & AMARA, S.G. (1991). Expression-cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature, 350, 350-354.
37. PINES, G., DANBOLT, N.C., BJORAS, M., ZHANG, Y., BENDAHAN, A., EIDIE, L., KEOPSELL, H., STORM-MATHISEN, J., SEBERG, E. & KANNER, B.I. (1992). Cloning and expression of a rat brain L-glutamate transporter. Nature, 360, 464-467.
38. 1 receptors of mouse neuroblastoma cells. Nature, 274, 176-177.
39. ROMER, J. & BICKEL, M.H. (1979). Interactions of chlorpromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. Biochem. Pharmacol., 28, 799-805.
40. SALT, P.J. (1972). Inhibition of noradrenaline uptake in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur. J. Pharmacol., 20, 329-340.
41. SCHILDKRAUT, J.J. (1965). The catecholamine hypothesis of affective disorders. Am. J. Psychiatry, 122, 509-522.
42. SMITH, P.K., KROHN, R.I., HERMANSON, G.T., MALLIA, A.K., GARTNER, F.H., PROVENZANO, M.D., FUJIMOTO, E.K., GOEKE, N.M., OLSON, B.J. & KLENK, D.C. (1985). Measurement of protein using bicinchoninic acid. Anal. Biochem., 150, 76-85.
43. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A., 89, 10955-10959.
44. U'PRICHARD, D.C., GREENBERG, D.A. SHEEHAN, P.P. & SNYDER, S.H. (1978). Tricyclic antidepressants: therapeutic properties and affinity for alpha noradrenergic receptor binding sites in the brain. Science, 199, 197-198.